Background

Amid the rapid decentralisation of healthcare and diagnostics following the COVID-19 pandemic, our client had identified a growing need for faster development of In Vitro Diagnostics (IVD) products to meet increasing demand for point-of-care testing.

Our client’s offering sought to address the inefficiencies in the traditional prototyping process, which was time-consuming and resource-intensive.

They asked White Space to contribute to their funding application by building a picture of the scale of the opportunity in the UK IVD market.

Approach

Our approach focused on understanding the market landscape, identifying key trends, and pinpointing the most promising opportunities for our client’s product.

Research comprised desktop research alongside interviews with experts in the UK IVD market. We analysed data from publicly available sources including industry reports and government publications. Benchmarking against competitor offerings allowed us to layer on a view of the opportunity for innovation.

By drawing on multiple sources, we were able to capture a broad view of the market complemented by detail and expert testimonials from interviews.

Outcome

Our report included a clear overview of the wider IVD market picture in the UK, Europe, and globally, as well as insight into primary areas of opportunity for our client.

This enabled our client to build a solid evidence base for their grant application, generating a comprehensive, compelling business case for their product ahead of its wider implementation.